• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

45岁及以下患者与老年患者口腔和口咽癌的全球发病率:一项系统评价。

Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review.

作者信息

Hussein Aisha A, Helder Marco N, de Visscher Jan G, Leemans C René, Braakhuis Boudewijn J, de Vet Henrica C W, Forouzanfar Tymour

机构信息

Department of Oral and Maxillofacial Surgery and Oral Pathology, VU University Medical Center/Academic Centre for Dentistry Amsterdam, Amsterdam, The Netherlands.

Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Eur J Cancer. 2017 Sep;82:115-127. doi: 10.1016/j.ejca.2017.05.026. Epub 2017 Jun 24.

DOI:10.1016/j.ejca.2017.05.026
PMID:28654785
Abstract

Head and neck squamous cell carcinoma (HNSCC) is typically regarded as a disease of elderly people. However, increasing numbers of patients worldwide with HNSCC at younger age (defined as <45 years old) have been reported in recent years. To assess geographical variations and trends worldwide in incidence of oral and oropharyngeal cancer in young patients, a systematic review was conducted in PubMed and Google scholar databases from 1975 to June 2016. Seventy-eight studies were selected for further study. Nineteen population-based studies on incidence rate were available from 13 countries, showing a prominent increase over time except for the Netherlands. A notable rise of oral (mobile) tongue cancer among white women and oropharyngeal cancer in white men was observed. Data suggest that cancer in young patients may be a distinct clinical entity and characterised by different aetiology and pathogenesis. Additionally, the relative proportion of oral and oropharyngeal cancer in young patients to total incidence revealed a significant difference between estimates from North America (5.5%) and both Africa (17.2%) and Middle East (14.5%). It is concluded that (i) a rising trend in oral and oropharynx cancers is observed in young patients worldwide; (ii) incidence studies should properly define outcomes in age cohorts and use a consensus cut-off for young patients; (iii) more population-based studies should be performed in non-Western regions to get accurate global measures of incidence for these cancers in young subpopulations and (iv) there is an urge to identify new aetiological factors in these young patients.

摘要

头颈部鳞状细胞癌(HNSCC)通常被认为是一种老年人疾病。然而,近年来全球范围内报告的年龄较轻(定义为<45岁)的HNSCC患者数量不断增加。为了评估全球年轻患者口腔癌和口咽癌发病率的地理差异和趋势,我们在PubMed和谷歌学术数据库中对1975年至2016年6月期间进行了系统综述。共筛选出78项研究进行进一步分析。来自13个国家的19项基于人群的发病率研究表明,除荷兰外,发病率随时间显著上升。观察到白人女性口腔(活动)舌癌和白人男性口咽癌显著增加。数据表明,年轻患者的癌症可能是一种独特的临床实体,并具有不同的病因和发病机制。此外,年轻患者口腔癌和口咽癌在总发病率中的相对比例在北美(5.5%)与非洲(17.2%)和中东(14.5%)的估计值之间存在显著差异。研究得出以下结论:(i)全球年轻患者口腔癌和口咽癌呈上升趋势;(ii)发病率研究应在年龄队列中正确定义结果,并对年轻患者采用一致的年龄界限;(iii)应在非西方地区开展更多基于人群的研究,以准确衡量这些癌症在年轻亚人群中的全球发病率;(iv)迫切需要确定这些年轻患者的新病因。

相似文献

1
Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review.45岁及以下患者与老年患者口腔和口咽癌的全球发病率:一项系统评价。
Eur J Cancer. 2017 Sep;82:115-127. doi: 10.1016/j.ejca.2017.05.026. Epub 2017 Jun 24.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.成人癫痫新药的临床疗效、耐受性及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. doi: 10.3310/hta9150.
8
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
9
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
10
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.

引用本文的文献

1
Field cancerization in women without conventional risk factors: insights from a case-cohort study.无传统风险因素女性的场癌化:一项病例队列研究的见解
Front Oral Health. 2025 Aug 14;6:1653210. doi: 10.3389/froh.2025.1653210. eCollection 2025.
2
Therapeutic potential of betaine and its derivatives in cancer treatment: a comprehensive review.甜菜碱及其衍生物在癌症治疗中的治疗潜力:综述
RSC Adv. 2025 Jun 17;15(26):20605-20622. doi: 10.1039/d5ra00755k. eCollection 2025 Jun 16.
3
Current challenges and potential opportunities for interception and prevention of head and neck cancer.
头颈部癌症拦截与预防的当前挑战及潜在机遇
Carcinogenesis. 2025 Apr 3;46(2). doi: 10.1093/carcin/bgaf025.
4
Carnosine alleviates oxidative stress to prevent cellular senescence by regulating Nrf2/HO-1 pathway: a promising anti-aging strategy for oral mucosa.肌肽通过调节Nrf2/HO-1通路减轻氧化应激以预防细胞衰老:一种有前景的口腔黏膜抗衰老策略。
Front Pharmacol. 2025 Apr 10;16:1559584. doi: 10.3389/fphar.2025.1559584. eCollection 2025.
5
Radiotherapy outcomes and risk factors for young patients with head-and-neck squamous cell carcinomas: a matched-pair analysis.年轻头颈鳞状细胞癌患者的放疗结果及危险因素:一项配对分析
Radiat Oncol. 2025 Apr 22;20(1):62. doi: 10.1186/s13014-025-02631-w.
6
Vessel Co-option: A Promising Therapeutic Strategy in Oral Squamous Cell Carcinoma.血管共选:口腔鳞状细胞癌中一种有前景的治疗策略。
Cureus. 2025 Feb 24;17(2):e79572. doi: 10.7759/cureus.79572. eCollection 2025 Feb.
7
Inflammatory Biomarkers and Oral Health Disorders as Predictors of Head and Neck Cancer: A Retrospective Longitudinal Study.炎症生物标志物与口腔健康障碍作为头颈癌的预测指标:一项回顾性纵向研究
Int J Mol Sci. 2025 Mar 4;26(5):2279. doi: 10.3390/ijms26052279.
8
The prognostic significance of tertiary lymphoid structures in oral squamous cell carcinomas: a systematic review.口腔鳞状细胞癌中三级淋巴结构的预后意义:一项系统评价。
Front Oral Health. 2025 Jan 22;5:1524313. doi: 10.3389/froh.2024.1524313. eCollection 2024.
9
Examining the Impact of Race and Sex on the Incidence of Positive Surgical Margins in Oral Cavity Squamous Cell Carcinoma.探讨种族和性别对口腔鳞状细胞癌手术切缘阳性发生率的影响。
Head Neck. 2025 May;47(5):1512-1519. doi: 10.1002/hed.28075. Epub 2025 Jan 16.
10
Factors associated with the survival of oral cavity cancer patients: a single institution experience from Karachi, Pakistan.与口腔癌患者生存相关的因素:来自巴基斯坦卡拉奇的单机构经验。
BMC Oral Health. 2024 Nov 22;24(1):1427. doi: 10.1186/s12903-024-04920-4.